IN2012DN03074A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03074A
IN2012DN03074A IN3074DEN2012A IN2012DN03074A IN 2012DN03074 A IN2012DN03074 A IN 2012DN03074A IN 3074DEN2012 A IN3074DEN2012 A IN 3074DEN2012A IN 2012DN03074 A IN2012DN03074 A IN 2012DN03074A
Authority
IN
India
Prior art keywords
analogs
disease
treatment
well
pharmacokinetic properties
Prior art date
Application number
Inventor
Kazimierz A Wisniewski
Claudio Daniel Schteingart
Sudarkodi Alagarsamy
Guangcheng Jian
Pierre Riviere
Javier Sueiras-Diaz
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09173900A external-priority patent/EP2314616A1/en
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of IN2012DN03074A publication Critical patent/IN2012DN03074A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Novel GLP-2 analogs with improved pharmacokinetic properties are described as well as their use in the treatment of disease.
IN3074DEN2012 2009-10-23 2010-10-21 IN2012DN03074A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25449009P 2009-10-23 2009-10-23
EP09173900A EP2314616A1 (en) 2009-10-23 2009-10-23 Peptidic GLP-2 agonists
PCT/US2010/053570 WO2011050174A1 (en) 2009-10-23 2010-10-21 Peptidic glp-2 agonists

Publications (1)

Publication Number Publication Date
IN2012DN03074A true IN2012DN03074A (en) 2015-07-31

Family

ID=53052624

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3074DEN2012 IN2012DN03074A (en) 2009-10-23 2010-10-21

Country Status (4)

Country Link
HR (1) HRP20150211T1 (en)
IN (1) IN2012DN03074A (en)
SA (1) SA110310791B1 (en)
SM (1) SMT201500065B (en)

Also Published As

Publication number Publication date
SMT201500065B (en) 2015-05-05
SA110310791B1 (en) 2014-06-04
HK1173659A1 (en) 2013-05-24
HRP20150211T1 (en) 2015-06-05

Similar Documents

Publication Publication Date Title
JO3026B1 (en) Peptidic glp-2 agonists
IN2012DN02737A (en)
EA201270619A1 (en) USE OF BETANEHOL FOR THE TREATMENT OF XEROSTOMY
MX2012013375A (en) Pegylated c-peptide.
EA201170465A1 (en) METHODS OF TREATMENT OF PROGRESSIVE MULTIPLE SCLEROSIS
MX2011007930A (en) Crystalline insulin-conjugates.
TN2012000161A1 (en) Spiro-oxindole mdm2 antagonists
UA102432C2 (en) Neuropeptide y-cytotoxic conjugates
IT1395519B1 (en) COMPOSITE PIECE, AS WELL AS THE USE OF THE COMPOSITE PIECE
IN2014DN06104A (en)
AP2014007399A0 (en) Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament
MX356728B (en) Pharmaceutical combination for use in the treatment of diabetes type 2.
CL2011001427A1 (en) Compounds derived from 4-azetidinyl-1-heteroaryl-cyclohexanol; pharmaceutical composition; and use in the treatment of diseases such as epoc, atherosclerosis, rheumatoid arthritis, among others.
MX357656B (en) Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases.
GB201010958D0 (en) Process for manufacturing perfluoroolefins by pyrolysis of perfluorocarbons in the presence of hydrogen
UA96574C2 (en) Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
IN2012DN03074A (en)
MX2012004727A (en) Peptidic glp-2 agonists.
UA44395U (en) Use of tiocetam as a diuretic drug with mild emictory action in a complex treatment
AU329952S (en) Book
MX2012012509A (en) Tapentadol for use in the treatment of irritable bowel syndrome.
TH93145B (en) Electrical calculator
UA41660U (en) Use of jacton and mexidol as actoprotector
TH98454B (en) Connection device
HUP0900258A2 (en) The treatment of brain tumours by pyrithiamine